Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 17.

Blagojevic, J; Bellando-Randone, S; Abignano, G; Avouac, J; Cometi, L; Czirják, L; Denton, C P; Distler, O; Frerix, M; Guiducci, S; Huscher, D; Jaeger, V K; Lóránd, V; Maurer, B; Nihtyanova, S; Riemekasten, G; Siegert, E; Tarner, I H; Vettori, S; Walker, U A; Allanore, Y; Müller-Ladner, U; Del Galdo, F; Matucci-Cerinic, M; EUSTAR co-workers (2019). Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey. Arthritis Research & Therapy, 21(1):35.

Carreira, P E; Carmona, L; Joven, B E; Loza, E; Andréu, J L; Riemekasten, G; Vettori, S; Balbir-Gurman, A; Airò, P; Walker, U; Damjanov, N; Matucci-Cerinic, M; Ananieva, L P; Rednic, S; Czirják, L; Distler, Oliver; Farge, D; Hesselstrand, R; Corrado, A; Caramaschi, P; Tikly, M; Allanore, Y; EUSTAR co-authors (2019). Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database. Scandinavian Journal of Rheumatology, 48(1):42-51.

Fransen, J; Johnson, S R; van den Hoogen, F; Baron, M; Allanore, Y; Carreira, P E; Czirják, L; Denton, C P; Distler, O; Furst, D E; Gabrielli, A; Herrick, A; Inanc, M; Kahaleh, B; Kowal-Bielecka, O; Medsger, T A; Mueller-Ladner, U; Riemekasten, G; Sierakowski, S; Valentini, G; Veale, D; Vonk, M C; Walker, U; Chung, L; Clements, P J; Collier, D H; Csuka, M E; Jimenez, S; Merkel, P A; Seibold, J R; Silver, R; Steen, V; Tyndall, A; Matucci-Cerinic, M; Pope, J E; Khanna, D (2012). Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise with the ACR/EULAR working committee for classification criteria in systemic sclerosis. Arthritis Care and Research, 64(3):351-357.

Distler, J H W; Jordan, S; Airo, P; Alegre-Sancho, J J; Allanore, Y; Balbir Gurman, A; Caporali, R; Caramaschi, P; Carreira, P E; Chizzolini, C; Cutolo, M; Tuncay Duruöz, M; Farge-Bancel, D; Hesselstrand, R; Iannone, F; De Keyser, F; Kucharz, E J; Launay, D; García de la Peña Lefebvre, P; Lukacova, O; Marasini, B; Martinovic, D; Marques Neto, J F; Radic, M; Rednic, S; Riemekasten, G; Rovensky, J; Seidel, M F; Senel, S; Smith, V; Sunderkötter, C; Ton, E; van Laar, J M; Matucci-Cerinic, M; Müller Ladner, U; Distler, O (2011). Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique. Clinical and Experimental Rheumatology, 29(2 Suppl 65):S40-S45.

Avouac, J; Fransen, J; Walker, U A; Riccieri, V; Smith, V; Muller, C; Miniati, I; Tarner, I H; Randone, S B; Cutolo, M; Allanore, Y; Distler, O; Valentini, G; Czirjak, L; Müller-Ladner, U; Furst, D E; Tyndall, A; Matucci-Cerinic, M (2011). Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Annals of the Rheumatic Diseases, 70(3):476-481.

Denton, C P; Avouac, J; Behrens, F; Furst, D E; Foeldvari, I; Humbert, M; Huscher, D; Kowal-Bielecka, O; Matucci-Cerinic, M; Nash, P; Opitz, C F; Pittrow, D; Rubin, L J; Seibold, J R; Distler, O (2011). Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed. Arthritis Research & Therapy, 13(3):114.

Kowal-Bielecka, O; Avouac, J; Pittrow, D; Huscher, D; Behrens, F; Denton, C P; Foeldvari, I; Humbert, M; Matucci-Cerinic, M; Nash, P; Opitz, C F; Rubin, L J; Seibold, J R; Strand, V; Furst, D E; Distler, O (2010). Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group. Journal of Rheumatology, 37(1):105-115.

Huscher, D; Pittrow, D; Distler, O; Denton, C P; Foeldvari, I; Humbert, M; Matucci-Cerinic, M; Kowal-Bielecka, O; Avouac, J; Behrens, F; Nash, P; Opitz, C F; Rubin, L J; Seibold, J R; Strand, V; Furst, D E; EPOSS-OMERACT Group (2010). Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis. Clinical and Experimental Rheumatology, 28(2 S 58):S47-52.

Guiducci, S; Distler, J H W; Milia, A F; Miniati, I; Rogai, V; Manetti, M; Falcini, F; Ibba-Manneschi, L; Gay, S; Distler, O; Matucci-Cerinic, M (2009). Stiff skin syndrome: evidence for an inflammation-independent fibrosis? Rheumatology, 48(7):849-852.

Distler, J H W; Allanore, Y; Avouac, J; Giacomelli, R; Guiducci, S; Moritz, F; Akhmetshina, A; Walker, U A; Gabrielli, A; Müller-Ladner, U; Tyndall, A; Matucci-Cerinic, M; Distler, O (2009). EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Annals of the Rheumatic Diseases, 68(2):163-168.

Khanna, D; Distler, O; Avouac, J; Behrens, F; Clements, P J; Denton, C; Foeldvari, I; Giannini, E; Huscher, D; Kowal-Bielecka, O; Lovell, D; Matucci-Cerinic, M; Mayes, M; Merkel, P A; Nash, P; Opitz, C F; Pittrow, D; Rubin, L; Seibold, J R; Steen, V; Strand, C V; Tugwell, P S; Varga, J; Zink, A; Furst, D E (2009). Measures of response in clinical trials of systemic sclerosis: the combined response index for systemic sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS). Journal of Rheumatology, 36(10):2356-2361.

Distler, O; Matucci-Cerinic, M; Muller-Ladner, U; Seibold, J R (2008). A path to the future in scleroderma. Rheumatology, 47(Suppl 5):v1.

Guiducci, S; Distler, O; Distler, J H W; Matucci-Cerinic, M (2008). Mechanisms of vascular damage in SSc--implications for vascular treatment strategies. Rheumatology, 47(Supplement):v18-v20.

Distler, O; Behrens, F; Pittrow, D; Huscher, D; Denton, C P; Foeldvari, I; Humbert, M; Matucci-Cerinic, M; Nash, P; Opitz, C F; Rubin, L J; Seibold, J R; Furst, D E (2008). Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis. Arthritis and Rheumatism, 59(6):867-875.

Guiducci, S; Distler, J H W; Jüngel, A; Huscher, D; Huber, L C; Michel, B A; Gay, R E; Pisetsky, D S; Gay, S; Matucci-Cerinic, M; Distler, O (2008). The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis and Rheumatism, 58(9):2845-2853.

Huber, L C; Distler, J H W; Moritz, F; Hemmatazad, H; Hauser, T; Michel, B A; Gay, R E; Matucci-Cerinic, M; Gay, S; Distler, O; Jüngel, A (2007). Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis and Rheumatism, 56(8):275-264.

Distler, O; Del Rosso, A; Giacomelli, R; Cipriani, P J; Conforti, M L; Guiducci, S G; Gay, R E; Michel, B A; Brühlmann, P; Müller-Ladner, U; Gay, S; Matucci-Cerinic, M (2002). Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Research, 4:R11.

This list was generated on Thu Feb 21 20:02:31 2019 CET.